Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

NCT00919035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: torisel

Sponsor

Oncology Specialists, S.C.

Collaborators

[object Object]